Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
Roche,Atezolizumab,Advanced NSCLC 1L combination therapy with platinum chemotherapy,Atezolizumab,,,Oncology Agents and Immunosuppressants
